MedPath
HSA Approval

DOXYCAP CAPSULE U.S.P. 100 mg

SIN08101P

DOXYCAP CAPSULE U.S.P. 100 mg

DOXYCAP CAPSULE U.S.P. 100 mg

April 5, 1995

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01AA02

doxycycline

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

HOVID Bhd.

Active Ingredients

Doxycycline Hyclate 122.55mg eqv doxycycline

100 mg

Doxycycline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DOXYCAP CAPSULE U.S.P. 100 mg - HSA Approval | MedPath